Get started
111

OPTUS PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

131030 chart


Full chart

131030 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪86.74 B‬ KRW
Dividend yield (indicated)
1.80%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
620 KRW
Net income (FY)
‪10.76 B‬ KRW
Revenue (FY)
‪72.43 B‬ KRW
Shares float
‪8.33 M‬
Beta (1Y)
1.37

Employees


Employees (FY)
204
Change (1Y)
+33 +19.30%
Revenue / Employee (1Y)
‪272.66 K‬ KRW
Net income / Employee (1Y)
‪40.51 K‬ KRW

About OPTUS PHARMACEUTICAL


Sector
Health Technology
CEO
Eun-Young Park
Headquarters
Cheongju-si
Website
optuspharm.com
Founded
2010
ISIN
KR7131030009
FIGI
BBG0018D6WC0
OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. Its products include artificial tears, eye drops, antibiotic ophthalmic solutions, and ethyl chloride spray. The company was founded on July 27, 2010 and is headquartered in Cheongju-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

131030 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 131030 is 5,430 KRW — it has decreased by −2.16% in the past 24 hours. Watch OPTUS PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OPTUS PHARMACEUTICAL stocks are traded under the ticker 131030.
131030 stock has fallen by −1.45% compared to the previous week, the month change is a −18.10% fall, over the last year OPTUS PHARMACEUTICAL has showed a 4.02% increase.
131030 reached its all-time high on Feb 5, 2015 with the price of 17,600 KRW, and its all-time low was 3,210 KRW and was reached on Sep 26, 2011. View more price dynamics on 131030 chart.
See other stocks reaching their highest and lowest prices.
131030 stock is 3.53% volatile and has beta coefficient of 1.37. Track OPTUS PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is OPTUS PHARMACEUTICAL there?
Today OPTUS PHARMACEUTICAL has the market capitalization of ‪84.77 B‬, it has increased by 5.51% over the last week.
Yes, you can track OPTUS PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
OPTUS PHARMACEUTICAL is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
131030 net income for the last quarter is ‪1.52 B‬ KRW, while the quarter before that showed ‪2.42 B‬ KRW of net income which accounts for −37.30% change. Track more OPTUS PHARMACEUTICAL financial stats to get the full picture.
Yes, 131030 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.80%. Tracking OPTUS PHARMACEUTICAL dividends might help you take more informed decisions.
OPTUS PHARMACEUTICAL dividend yield was 1.88% in 2023, and payout ratio reached 14.12%. The year before the numbers were 1.59% and 31.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 204.00 employees. See our rating of the largest employees — is OPTUS PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTUS PHARMACEUTICAL EBITDA is ‪11.37 B‬ KRW, and current EBITDA margin is 17.15%. See more stats in OPTUS PHARMACEUTICAL financial statements.
Like other stocks, 131030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTUS PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTUS PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTUS PHARMACEUTICAL stock shows the strong sell signal. See more of OPTUS PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.